| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
118,703
|
217,305
|
177,701
|
141,166
| | Cost of Revenue | 81,237 | 81,717 | 84,708 | 73,560 | | |
Gross Profit
|
37,466
|
135,588
|
92,993
|
67,606
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 23,084 | 26,165 | 24,886 | 25,727 |
|
Non Recurring |
-
| 1,024,426 | 546,834 | 736,740 |
|
Others | 18,256 | 14,034 | 43,209 | 51,942 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(3,874)
|
(929,037)
|
(521,936)
|
(746,803)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (36,364) | (3,578) | (5,372) | 1,898 |
|
Earnings Before Interest And Taxes | (8,869) | (932,615) | (527,308) | (751,569) |
|
Interest Expense | 43,942 | 41,703 | 42,102 | 40,076 |
|
Income Before Tax | (52,811) | (974,318) | (569,410) | (791,645) |
|
Income Tax Expense | 6,896 | (5,939) | 82,352 | (270,745) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (59,707) | (968,379) | (651,762) | (520,900) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(59,707)
|
(968,379)
|
(651,762)
|
(520,900)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(59,707)
|
(968,379)
|
(651,762)
|
(520,900)
|
|